PTAB Tosses Two More Humira Patents; Will Supreme Court Eliminate IPR Proceeding?
Executive Summary
Patent Trial and Appeal Board rules for Coherus in its challenge of Humira patents and takes up review of Cialis patent. US high court to consider constitutionality of inter partes review proceeding.
You may also be interested in...
Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents
District court questions legitimacy of Allergan's patent transfer tactic, saying it 'could spell the end of the PTO's IPR program.'
Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents
District court questions legitimacy of Allergan's patent transfer tactic, saying it 'could spell the end of the PTO's IPR program.'
IPR Battles Could Become Easier For BioPharma Patent Owners
En banc Federal Circuit says patent owners do not have to prove patentability of amended claims in inter partes review proceedings; judges issue five opinions in fractured decision.